These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25564210)

  • 21. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
    Lin G; Han SY; Xu YP; Mao WM
    Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.
    Bartels H; Stein HJ; Siewert JR
    Br J Surg; 1998 Jun; 85(6):840-4. PubMed ID: 9667720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the optimal interval between chemoradiation and esophagectomy?
    Martin LW
    Semin Thorac Cardiovasc Surg; 2012; 24(2):87-9. PubMed ID: 22920522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.
    Sabra MJ; Smotherman C; Kraemer DF; Nussbaum MS; Tepas JJ; Awad ZT
    J Surg Oncol; 2017 Mar; 115(3):296-300. PubMed ID: 27813095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
    Fuchs HF; Hölscher AH
    Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery of gastric cancer and esophageal cancer: Does age matter?
    Nienhueser H; Kunzmann R; Sisic L; Blank S; Strowitzk MJ; Bruckner T; Jäger D; Weichert W; Ulrich A; Büchler MW; Ott K; Schmidt T
    J Surg Oncol; 2015 Sep; 112(4):387-95. PubMed ID: 26303645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time shift in early postoperative mortality after oesophagectomy for cancer.
    Rutegård M; Lagergren P; Johar A; Lagergren J
    Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival after oesophagectomy for cancer of the oesophagus.
    Stein HJ; von Rahden BH; Siewert JR
    Langenbecks Arch Surg; 2005 Aug; 390(4):280-5. PubMed ID: 15252736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of volume on outcomes after oesophageal cancer surgery.
    Rouvelas I; Lagergren J
    ANZ J Surg; 2010 Sep; 80(9):634-41. PubMed ID: 20840408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy.
    Thomson IG; Wallen MP; Hall A; Ferris R; Gotley DC; Barbour AP; Lee A; Thomas J; Smithers BM
    Int J Surg; 2018 May; 53():86-92. PubMed ID: 29555526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
    Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
    BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone.
    Vincent J; Mariette C; Pezet D; Huet E; Bonnetain F; Bouché O; Conroy T; Roullet B; Seitz JF; Herr JP; Di Fiore F; Jouve JL; Bedenne L;
    Eur J Cancer; 2015 Sep; 51(13):1683-93. PubMed ID: 26163097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
    Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.
    Stiles BM; Nasar A; Mirza FA; Lee PC; Paul S; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):659-64. PubMed ID: 22491667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-oesophagectomy mortality: the centralization debate revisited.
    Keong B; Cade R; Mackay S
    ANZ J Surg; 2016 Mar; 86(3):116-7. PubMed ID: 26940179
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimally invasive oesophagectomy in Wales.
    Chan DS; Baker AL
    Surgeon; 2016 Aug; 14(4):196-201. PubMed ID: 25596667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.